If we find any, we delete them and, if necessary, take action against whoever is responsible.Īnyone who spots something suspicious can always report it to our Customer Service team so that our fraud team can investigate. We have people and automated systems that specialize in detecting fake reviews submitted to our platform. To edit a review you’ve already submitted, contact our Customer Service team. You can review an accommodation that you booked through our platform if you stayed there, or if you got to the property but didn’t actually stay there. Guests submit their subscores and their overall scores independently – there’s no direct link between them. Guests can also give separate subscores in crucial areas, such as location, cleanliness, staff, comfort, facilities, value, and free WiFi. To get the overall score, we add up all the review scores and divide that total by the number of review scores we received. The company has a market cap of $230.47 million, a price-to-earnings ratio of -1.05 and a beta of 1.92.Each review score is between 1 and 10. Shares of MacroGenics stock opened at $3.75 on Friday. Qube Research & Technologies Ltd now owns 55,550 shares of the biopharmaceutical company's stock worth $489,000 after purchasing an additional 25,788 shares in the last quarter. Finally, Qube Research & Technologies Ltd boosted its stake in MacroGenics by 86.6% in the 1st quarter. Teacher Retirement System of Texas acquired a new stake in MacroGenics in the 1st quarter worth approximately $89,000. Ensign Peak Advisors Inc acquired a new stake in MacroGenics in the 4th quarter worth approximately $208,000. acquired a new stake in MacroGenics in the 1st quarter worth approximately $92,000. MA now owns 96,898 shares of the biopharmaceutical company's stock worth $854,000 after purchasing an additional 18,599 shares in the last quarter. MA boosted its stake in MacroGenics by 23.8% in the 1st quarter. Institutional investors have recently bought and sold shares of the stock. Finally, HC Wainwright cut their target price on shares of MacroGenics from $35.00 to $10.00 and set a "buy" rating on the stock in a research report on Monday, September 12th. SVB Leerink cut their target price on shares of MacroGenics from $15.00 to $12.00 and set an "outperform" rating on the stock in a research report on Tuesday, August 9th. Citigroup raised their target price on shares of MacroGenics from $13.00 to $16.00 and gave the company a "buy" rating in a research report on Monday, August 29th. JMP Securities reduced their price target on shares of MacroGenics from $24.00 to $20.00 and set a "market outperform" rating on the stock in a research note on Tuesday, July 12th. Barclays reduced their price target on shares of MacroGenics to $8.00 in a research note on Monday, August 15th. Several research analysts recently commented on the stock. The average 12 month target price among analysts that have covered the stock in the last year is $10.13. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. ( NASDAQ:MGNX - Get Rating) have earned an average recommendation of "Moderate Buy" from the ten brokerages that are currently covering the firm, Marketbeat reports. 7 Blue-Chip Dividend Stocks That Won’t be Impacted by Rising Interest Rates.7 Mid-Cap Stocks That Can be the Perfect Fit at Any Time.7 Stocks to Buy to Outrun Rising Interest Rates.7 Sports Betting Stocks to Buy for Their Long-Term Possibilities.7 Water Stocks to Buy as the World Dries Up.7 Solar Stocks Leading the Clean Energy Boom.7 Railroad Stocks to Keep Your Portfolio Chugging Along.7 Agricultural Stocks to Buy to Keep Your Portfolio Well Fed.7 Streaming Stocks that Will Stand up to Streaming Fatigue.7 Cash Rich Stocks That Offer Safety in Any Market. 7 Small-Cap Stocks That Could Rocket Higher in 2023.Fisker is Entering a Critical Stage That Could Reward Investors.Google, Amazon and Tesla, Why These 3 Big Stocks Are Likely to Move Higher.Biogen's Stock Pullback Offers a Second Chance.Google, Amazon and Tesla, 3 Big Stocks Set to Move Higher.Cloudflare Lights Up With 13% Gain After Wells Fargo Upgrade.Twilio and Its 65% Upside Going Into Q4.Lockheed Martin: Get Defensive With Defense Stocks.Another Relief Rally? Here’s a Playbook for Traders and Investors.Will Goldman Sachs' Earnings & Revenue Beats Lift Sector Higher?.The Trader's Guide to Equities Research.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |